1. Uveal Metastasis Based on Patient Sex in 2214 Tumors of 1111 Patients. A Comparison of Female Versus Male Clinical Features and Outcomes.
- Author
-
Welch RJ, Malik K, Considine SP, Acaba-Berrocal LA, Selzer EB, Newman JH, Shields JA, and Shields CL
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Follow-Up Studies, Humans, Male, Microscopy, Acoustic, Middle Aged, Neoplasm Metastasis, Prognosis, Retrospective Studies, Sex Distribution, Sex Factors, Survival Rate trends, United States epidemiology, Uveal Neoplasms diagnosis, Uveal Neoplasms mortality, Young Adult, Uvea pathology, Uveal Neoplasms secondary
- Abstract
Background: Lacking in previous studies on uveal metastasis is a robust statistical comparison of patient demographics, tumor features, and overall survival based on patient sex., Objective: The aim of this study was to evaluate demographics, clinical features, and overall survival of patients with uveal metastasis based on sex., Method: This is a retrospective analysis. All patients were evaluated on the Ocular Oncology Service, Wills Eye Hospital, PA between January 1, 1974 and June 1, 2017., Results: A total of 2214 uveal metastases were diagnosed in 1310 eyes of 1111 consecutive patients. A comparison (female versus male) revealed differences across several demographic and clinical features including, among others, mean age at metastasis diagnosis (58 vs 63 years, P < 0.001), bilateral disease (21% vs 11%, P < 0.001), and mean number of metastases per eye (1.8 vs 1.6 tumors per eye, P = 0.04). There were differences in overall mean survival (20 vs 13 months, P = 0.03) and 5-year survival (Kaplan-Meier estimate) (31% vs 21%, P < 0.001)., Conclusions: There are demographic, clinical, and survival differences when patients with uveal metastases are compared by sex. Understanding these differences can aid the clinician in better anticipating patient outcomes.
- Published
- 2019
- Full Text
- View/download PDF